Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($) $ in Thousands |
Total |
Common Stock |
Additional Paid-in Capital |
Accumulated Other Comprehensive Income (Loss) |
Accumulated Deficit |
Beginning Balance at Nov. 30, 2020 |
$ 290,269
|
$ 39
|
$ 393,841
|
$ 87
|
$ (103,698)
|
Beginning Balance, Shares at Nov. 30, 2020 |
|
38,864,872
|
|
|
|
Exercise of stock options |
394
|
|
394
|
|
|
Exercise of stock options, Shares |
|
190,825
|
|
|
|
Repurchase of unvested early exercised stock options, Shares |
|
(971)
|
|
|
|
Vesting of early-exercised stock options |
40
|
|
40
|
|
|
Issuance under employee stock purchase plan |
1,043
|
|
1,043
|
|
|
Issuance under employee stock purchase plan, Shares |
|
64,589
|
|
|
|
Stock-based compensation |
2,700
|
|
2,700
|
|
|
Unrealized loss on available-for-sale securities |
(38)
|
|
|
(38)
|
|
Net loss |
(24,275)
|
|
|
|
(24,275)
|
Ending Balance at Feb. 28, 2021 |
270,133
|
$ 39
|
398,018
|
49
|
(127,973)
|
Ending Balance, Shares at Feb. 28, 2021 |
|
39,119,315
|
|
|
|
Beginning Balance at Nov. 30, 2020 |
290,269
|
$ 39
|
393,841
|
87
|
(103,698)
|
Beginning Balance, Shares at Nov. 30, 2020 |
|
38,864,872
|
|
|
|
Net loss |
(79,492)
|
|
|
|
|
Ending Balance at Aug. 31, 2021 |
375,217
|
$ 45
|
558,421
|
(59)
|
(183,190)
|
Ending Balance, Shares at Aug. 31, 2021 |
|
44,556,604
|
|
|
|
Beginning Balance at Feb. 28, 2021 |
270,133
|
$ 39
|
398,018
|
49
|
(127,973)
|
Beginning Balance, Shares at Feb. 28, 2021 |
|
39,119,315
|
|
|
|
Issuance of common stock, net of offering\ issuance costs |
150,157
|
$ 5
|
150,152
|
|
|
Issuance of common stock, net of offering\ issuance costs, Shares |
|
5,175,000
|
|
|
|
Exercise of stock options |
241
|
|
241
|
|
|
Exercise of stock options, Shares |
|
109,232
|
|
|
|
Vesting of early-exercised stock options |
104
|
|
104
|
|
|
Stock-based compensation |
3,944
|
|
3,944
|
|
|
Unrealized loss on available-for-sale securities |
(19)
|
|
|
(19)
|
|
Net loss |
(26,382)
|
|
|
|
(26,382)
|
Ending Balance at May. 31, 2021 |
398,178
|
$ 44
|
552,459
|
30
|
(154,355)
|
Ending Balance, Shares at May. 31, 2021 |
|
44,403,547
|
|
|
|
Exercise of stock options |
584
|
$ 1
|
583
|
|
|
Exercise of stock options, Shares |
|
114,182
|
|
|
|
Vesting of early-exercised stock options |
49
|
|
49
|
|
|
Issuance under employee stock purchase plan |
1,017
|
|
1,017
|
|
|
Issuance under employee stock purchase plan, Shares |
|
38,875
|
|
|
|
Stock-based compensation |
4,313
|
|
4,313
|
|
|
Unrealized loss on available-for-sale securities |
(89)
|
|
|
(89)
|
|
Net loss |
(28,835)
|
|
|
|
(28,835)
|
Ending Balance at Aug. 31, 2021 |
375,217
|
$ 45
|
558,421
|
(59)
|
(183,190)
|
Ending Balance, Shares at Aug. 31, 2021 |
|
44,556,604
|
|
|
|
Beginning Balance at Nov. 30, 2021 |
342,302
|
$ 45
|
563,757
|
(608)
|
(220,892)
|
Beginning Balance, Shares at Nov. 30, 2021 |
|
44,664,371
|
|
|
|
Exercise of stock options |
424
|
|
424
|
|
|
Exercise of stock options, Shares |
|
117,870
|
|
|
|
Vesting of early-exercised stock options |
47
|
|
47
|
|
|
Issuance under employee stock purchase plan |
1,064
|
|
1,064
|
|
|
Issuance under employee stock purchase plan, Shares |
|
71,207
|
|
|
|
Stock-based compensation |
6,071
|
|
6,071
|
|
|
Unrealized loss on available-for-sale securities |
(1,458)
|
|
|
(1,458)
|
|
Net loss |
(42,533)
|
|
|
|
(42,533)
|
Ending Balance at Feb. 28, 2022 |
305,917
|
$ 45
|
571,363
|
(2,066)
|
(263,425)
|
Ending Balance, Shares at Feb. 28, 2022 |
|
44,853,448
|
|
|
|
Beginning Balance at Nov. 30, 2021 |
342,302
|
$ 45
|
563,757
|
(608)
|
(220,892)
|
Beginning Balance, Shares at Nov. 30, 2021 |
|
44,664,371
|
|
|
|
Net loss |
(133,643)
|
|
|
|
|
Ending Balance at Aug. 31, 2022 |
342,545
|
$ 47
|
700,775
|
(3,742)
|
(354,535)
|
Ending Balance, Shares at Aug. 31, 2022 |
|
47,147,781
|
|
|
|
Beginning Balance at Feb. 28, 2022 |
305,917
|
$ 45
|
571,363
|
(2,066)
|
(263,425)
|
Beginning Balance, Shares at Feb. 28, 2022 |
|
44,853,448
|
|
|
|
Exercise of stock options |
432
|
|
432
|
|
|
Exercise of stock options, Shares |
|
173,155
|
|
|
|
Vesting of restricted stock units, Shares |
|
13,465
|
|
|
|
Vesting of early-exercised stock options |
35
|
|
35
|
|
|
Stock-based compensation |
6,775
|
|
6,775
|
|
|
Unrealized loss on available-for-sale securities |
(1,019)
|
|
|
(1,019)
|
|
Net loss |
(45,401)
|
|
|
|
(45,401)
|
Ending Balance at May. 31, 2022 |
266,739
|
$ 45
|
578,605
|
(3,085)
|
(308,826)
|
Ending Balance, Shares at May. 31, 2022 |
|
45,040,068
|
|
|
|
Issuance of pre-funded warrants, net of issuance costs of $234 |
94,759
|
|
94,759
|
|
|
Issuance of common stock, net of offering\ issuance costs |
19,328
|
$ 2
|
19,326
|
|
|
Issuance of common stock, net of offering\ issuance costs, Shares |
|
2,000,000
|
|
|
|
Exercise of stock options |
174
|
|
174
|
|
|
Exercise of stock options, Shares |
|
24,147
|
|
|
|
Vesting of restricted stock units, Shares |
|
18,469
|
|
|
|
Vesting of early-exercised stock options |
32
|
|
32
|
|
|
Issuance under employee stock purchase plan |
891
|
|
891
|
|
|
Issuance under employee stock purchase plan, Shares |
|
65,097
|
|
|
|
Stock-based compensation |
6,988
|
|
6,988
|
|
|
Unrealized loss on available-for-sale securities |
(657)
|
|
|
(657)
|
|
Net loss |
(45,709)
|
|
|
|
(45,709)
|
Ending Balance at Aug. 31, 2022 |
$ 342,545
|
$ 47
|
$ 700,775
|
$ (3,742)
|
$ (354,535)
|
Ending Balance, Shares at Aug. 31, 2022 |
|
47,147,781
|
|
|
|